These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


254 related items for PubMed ID: 18846961

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].
    Li ZH, Peng SC, Kang J, Hou XM, Yu RJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):887-91. PubMed ID: 21211406
    [Abstract] [Full Text] [Related]

  • 3. [Retrospective analysis of the prognosis factors in patients with idiopathic pulmonary fibrosis].
    Zhang J, Huang H, Lu ZW, Xu ZJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Mar; 34(3):174-8. PubMed ID: 21569682
    [Abstract] [Full Text] [Related]

  • 4. [Prognostic value of clinical exercise testing in idiopathic pulmonary fibrosis].
    Wallaert B, Guetta A, Wemeau-Stervinou L, Tercé G, Valette M, Nevière R, Aguilaniu B.
    Rev Mal Respir; 2011 Mar; 28(3):290-6. PubMed ID: 21482330
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
    Nakayama S, Mukae H, Ishii H, Kakugawa T, Sugiyama K, Sakamoto N, Fujii T, Kadota J, Kohno S.
    Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216
    [Abstract] [Full Text] [Related]

  • 13. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
    Kimura M, Taniguchi H, Kondoh Y, Kimura T, Kataoka K, Nishiyama O, Aso H, Sakamoto K, Hasegawa Y.
    Respiration; 2013 Sep; 85(6):456-63. PubMed ID: 23257350
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of interleukin-13 in the serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis].
    Xiao L, Li ZH, Hou XM, Yu RJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Nov; 26(11):686-8. PubMed ID: 14703444
    [Abstract] [Full Text] [Related]

  • 15. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
    Vasakova M, Sterclova M, Kolesar L, Slavcev A, Pohunek P, Sulc J, Skibova J, Striz I.
    Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Levels of cytokeratin 19 fragments in bronchoalveolar lavage fluid correlate to the intensity of neutrophil and eosinophil-alveolitis in patients with idiopathic pulmonary fibrosis.
    Inage M, Nakamura H, Kato S, Saito H, Abe S, Hino T, Tomoike H.
    Respir Med; 2000 Feb; 94(2):155-60. PubMed ID: 10714422
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis.
    Psathakis K, Mermigkis D, Papatheodorou G, Loukides S, Panagou P, Polychronopoulos V, Siafakas NM, Bouros D.
    Eur J Clin Invest; 2006 May; 36(5):362-7. PubMed ID: 16634841
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.